[Neurologic disorders and cervical spina bifida occulta].

A. Ricard,P. Girard,A. Garde

1950-11-01

Abstract:

What problem does this paper attempt to address?

Chest CT features of microscopic polyangiitis

Hua QU,Ri-sheng YU,Feng CUI,Bin ZHU

DOI: https://doi.org/10.3760/cma.j.issn.1005-1201.2011.05.005

2011-01-01

Abstract:Objective To evaluate chest CT features of microscopic polyangiitis(MPA).Methods Clinical data and chest CT images of 66 patients diagnosed as MAP had been collected.Depending on clinical manifestations.the 66 cases were divided into the active group and the stable group.The data of two groups were analyzed by x2 test.Results Forty-three of 66(65.2%)CT images were abnormal including 32 of them in active group and 11 in stable group. In these patients,CT images showed ground glass opacities(53.5%),lung consolidations(23.2%),scattered patchy opacities(44.2%),ground glass opacities and/or lung consolidations(76.7%),reticular opacities(65.1%),honeycomb(14.0%),pleural effusions(48.8%),emphysema(18.6%),and mediastinal adenopathies(58.1%).Lung consolidations,ground glass opacities,scattered patchy opacities,mediastinal adenopathies,and pleural effusion in the active group are more common than that in the stable group(X2=4.479,4.083,4.053,9.697,9.345 respectively,P<0.05).Conclusion Chest CT features of in patients with MPA have difference between active and stable periods.The chest CT scan is a useful tool to diagnose MAP in different periods and guide the treatment.
The Lung Involvement of Microscopic Polyangiitis

尹宏恩,张文,王京岚,于孟学,周炜,郑文洁

DOI: https://doi.org/10.3969/j.issn.1001-9057.2003.03.009

2003-01-01

Abstract:Objective To analyze the clinical and laboratory characters of lung involvement, effect of treatment and prognosis in patients with microscopic polyangiitis(MPA).Methods 16 patients meeting the Chapel Hill criteria for MPA participated in this study. The initial manifestations and laboratory findings of 12 with lung involvement were analyzed. All patients weighted by FFS?BVAS before and after 4～6weeks of comprehensive treatment.Results 10 men and 6 women ,with mean ±SD age of 52.5 ±15.3 years were included in this study. The initial manifestation of 12 patients with lung involvement were ILD (7/12), pulmonary hemorrhage (2/7), hydrothorax (2/7) and pneumonia (1/7). All ILD patients have pulmonary disfunction and HRCT was needed in diagnosing of 3/7 of them. 11/12of patients with lung involvement were with p-ANCA(+).There was no significant difference between patients with and without lung involvement except SCr. FFS, BVAS and laboratory findings were significantly improved after 4～6 weeks of comprehensive treatment except ANCA. 5 patients were known relapse.Conclusion Our study demonstrated that ILD is an common manifestation of early MPA. HRCT,pulmonary test and hemosiderin cells in BALF can be benefit to early diagnosis of ILD of MPA. p-ANCA is more common than c-ANCA in patients with lung involvement. Perhaps lung involvement is associated with renal involvement. MPA can be significantly controlled after comprehensive treatment, but relapse is frequent. Alveolar hemorrhage is one of markers of poor prognosis. \[
Manifestation and long-term prognosis in microscopic polyangiitis patients with pulmonary involvement

Fang SHAO,Yinghua CHEN,Lihuang ZHANG,Yuanmao TU,Weixin HU,Zhihong LIU,Honglang XIE

DOI: https://doi.org/10.3969/cndt.j.issn.1006-298X.2017.02.004

2017-01-01

Abstract:Objective:To analyze the clinical characteristics and long-term prognosis of patients with microscopic polyangiitis (MPA) with and without pulmonary involvement.Methodology:196 MPA patients with renal involvement were enrolled in the study.The median serum creatinine (SCr) was 344.8 (176.8 ～ 556.9) μmol/L,70 (35.7％) of them needed renal replacement therapy at diagnosis.The prognosis and risk factor of MPA with pulmonary involvement were retrospectively studied.Survival Curve was estimated by Kaplan-Meier methods,and multivariate Cox regression analysis is applied to probe into the correlation between clinical features as well as pathological parameters and long-term human survival outcome.Results:With a mean follow-up time of 38.9±42.0 months,20 patients died,81 (41.3％) developed end stage renal disease (ESRD).The pulmonary involvements were observed in 111 MPA patients,their main clinical symptoms included hemoptysis and cough;CT or X-ray manifestations included patchy,ftmicular shadow and pleural thickening.The age,proportion of male patients and smokers,BVAS score,serum creatinine and MPO-ANCA level in pulmonary involvement group were apparently higher than those of non-pulmonary involvement group (P＜0.05).The 1-year complete remission rate was 13.5％ and 21.2％(P =O.155) in patients with and without pulmonary involvement;while their ineffective treatment proportion was respectively 42.3％ and 35.3％ (P=0.317).Patient survival rate in pulmonary involvement group was significantly lower (P=0.013);renal survival was not differed between two groups.Cox multivariate analysis indicated that lung involvement and dialysis dependent on admission were significant negative prognostic factors for patients survival.Conclusion:The vasculitis of older MPA patients with lung damage was more active.Lung involvement was an independent risk factor for human survival.
Long-term clinical course and outcomes of patients with microscopic polyangiitis-associated interstitial lung disease

Min Jee Kim,Donghee Lee,Jooae Choe,Jin Woo Song

DOI: https://doi.org/10.3389/fphar.2023.1064307

2023-01-30

Abstract:Background: Interstitial lung disease (ILD) is a significant complication associated with microscopic polyangiitis (MPA) that has a poor prognosis. However, the long-term clinical course, outcomes, and prognostic factors of MPA-ILD are not well defined. Hence, this study aimed to investigate the long-term clinical course, outcomes, and prognostic factors in patients with MPA-ILD. Methods: Clinical data of 39 patients with MPA-ILD (biopsy proven cases, n = 6) were retrospectively analyzed. High resolution computed tomography (HRCT) patterns were assessed based on the 2018 idiopathic pulmonary fibrosis diagnostic criteria. Acute exacerbation (AE) was defined as the worsening of dyspnea within 30 days, with new bilateral lung infiltration that is not fully explained by heart failure or fluid overload and that does not have identified extra-parenchymal causes (pneumothorax, pleural effusion, or pulmonary embolism). Results: The median follow-up period was 72.0 months (interquartile range: 44-117 months). The mean age of the patients was 62.7 years and 59.0% were male. Usual interstitial pneumonia (UIP) and probable usual interstitial pneumonia patterns on high resolution computed tomography were identified in 61.5 and 17.9% of the patients, respectively. During the follow-up, 51.3% of patients died, and the 5- and 10-year overall survival rates were 73.5% and 42.0%, respectively. Acute exacerbation occurred in 17.9% of the patients. The non-survivors had higher neutrophil counts in bronchoalveolar lavage (BAL) fluid and more frequent acute exacerbation than the survivors. In the multivariable Cox analysis, older age (hazard ratio [HR], 1.07; 95% confidence interval [CI], 1.01-1.14; p = 0.028) and higher BAL counts (HR, 1.09; 95% CI, 1.01-1.17; p = 0.015) were found to be the independent prognostic factors associated with mortality in patients with MPA-ILD. Conclusion: During the 6 years-follow-up, about half of patients with MPA-ILD died and approximately one-fifth experienced acute exacerbation. Our results suggest that older age and higher BAL neutrophil counts mean poor prognosis in patients with MPA-ILD.
Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: A single-center retrospective study

Yukiko Takakuwa,Yoshioki Yamasaki,Hiromi Matsushita,Tomofumi Kiyokawa,Machiko Mizushima,Kumiko Tonooka,Hiroko Nagafuchi,Shin Matsuoka,Seido Ooka,Kimito Kawahata

DOI: https://doi.org/10.1111/1756-185X.14532

Abstract:Aim: To elucidate the clinical features, long-term survival, and prognostic factors for mortality among patients with microscopic polyangiitis (MPA), including those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease (ILD) (ANCA-ILD), which could be a subset of its variant phenotype. Methods: We retrospectively included 76 consecutive patients between 2006 and 2014, diagnosed with MPA according to the European Medicines Agency algorithm using the Chapel Hill Consensus Conference definitions or ANCA-ILD. ILD was classified as usual interstitial pneumonia (UIP) or nonspecific interstitial pneumonia pattern using chest computed tomography. Results: The mean (standard deviation) age of the patients (female, 68%) was 69 (12) years. The median (interquartile range) follow-up period was 68 (33-95) months. Comorbid ILD and glomerulonephritis were observed in 44 (58%) (68% UIP) and 54 (71%) patients, respectively. Comorbid ILD was associated with low survival (P = .0563). There were 17 (39%) and 5 (16%) deaths in the ILD and non-ILD groups, respectively (P = .0404). In the ILD group, 6 and 5 of the deaths were attributed to infection and ILD progression, respectively. In the non-ILD group, 1 and 2 patients expired from subsequently developed ILD and aspiration pneumonia, respectively. Age ≥ 70 years (hazard ratio = 2.78; 95% confidential interval 1.15-6.70) and UIP (3.95; 1.60-9.77) were independent risk factors for mortality. Conclusion: Age ≥ 70 years and ILD with a UIP pattern were associated with high mortality, owing to susceptibility to infection and ILD progression. A more effective and less toxic treatment is required for progressive ILD.
[Clinical characteristics of 15 cases of microscopic polyangiitis associated with alveolar hemorrhage].

Li Wang,Jing Li,Jing Zhao,Hua Chen,Wenjie Zheng,Qingjun Wu,Fengchun Zhang

DOI: https://doi.org/10.3760/cma.j.issn.0578-1426.2015.05.008

2015-01-01

Abstract:OBJECTIVE:To investigate the clinical features of patients with microscopic polyangiitis (MPA) and alveolar hemorrhage (AH), so as to raise the physicians' understanding of this condition. METHODS:The clinical data of 15 MPA patients combined with AH, who were hospitalized in Peking Union Medical College Hospital from January 2008 to January 2014, were retrospectively analyzed. RESULTS:These 15 subjects accounted for 18.1% of all MPA patients, including 4 males and 11 females with mean age of (59.4 ± 17.9) years old and mean disease duration of 7.5 (1-48) months. Hemoptysis or bloody sputum (14/15) and dyspnea (11/15) were predominant pulmonary manifestations. Hypoxemia appeared in 6 patients (40.0%). An average 8-46 (22.7 ± 4.4) g/L drop of hemoglobin level was seen in all 15 patients. Imaging revealed new bilateral infiltrations or opacities in 13 cases, and bloody bronchoalveolar lavage fluid were found in 6 cases. Compared with MPA patients without AH, the incidence of myalgia [2/15 vs 50.0%(34/68); P=0.009, OR=0.154] and hemoglobin level [(83.2 ± 21.0) g/L vs (102.5 ± 18.7) g/L; P=0.001] were statistically lower in MPA patients with AH. There were no statistical differences in age, sex, interstitial lung disease, renal involvement, peripheral neuropathy and the five factor score between two groups. The proportion of patients who received corticosteroid pulse treatment in MPA with AH group was significantly higher than that of MPA patients without AH [9/15 vs 19.1%(13/68); P=0.003, OR=6.346]. After treatment, 13 cases achieved remission, while 2 died. CONCLUSION:As an important pulmonary manifestation of MPA, AH could be insidious but fatal. The treatment with steroid, cyclophosphamide and plasma exchange could improve the prognosis.
The Clinical and Pathological Features of Children With Microscopic Polyangiitis

Qian Li,Li-Chun Yu,Feng-Xia Li,Jing Wang,Yuan Chen,Shu-Zhen Sun

DOI: https://doi.org/10.3389/fped.2021.645785

IF: 3.569

2021-04-15

Frontiers in Pediatrics

Abstract:Objective: The aim of this study was to explore the clinical features, pathological characteristics, and the prognosis of children with microscopic polyangiitis (MPA). Methods: Ten children with MPA that were hospitalized in our hospital were included in this study. The children's pre-diagnosis status, clinical manifestations, renal pathology, treatment, and prognosis data were analyzed retrospectively. Results: All 10 cases included female patients with a median age of 8.9 years old at the time of diagnosis. MPO-ANCA antibody was positive in all cases, combined with a positive anti-GBM antibody in two cases. Nine cases had primary AAV and one had antithyroid drug (ATD)-associated MPA (secondary to methimazole). Renal involvement was found in all 10 patients, lung impairment was present in eight cases, and anemia was present in nine patients. Renal biopsies were performed in all 10 patients. Segmental focal or global glomerular necrosis was observed in 70% of the patients (7/10). The treatment mainly included steroid use combined with Cyclophosphamide and Mycophenolate. The follow-up s of the patients revealed normal renal function in eight patients and progression to end-stage renal disease (ESRD) in two patients. Conclusions: Female predisposition and positive MPO-ANCA antibody were prominent in children with MPA. The patients' kidneys and lungs were the most frequently involved organs. Corticosteroid combined with immunosuppressive therapy was recommended for the treatment of MPA. Early diagnosis, prompt aggressive treatment, and regular follow-ups are also very important factors associated with a good prognosis.

pediatrics
Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody

Xin Sun,Min Peng,Ting Zhang,Zongru Li,Lan Song,Mengtao Li,Juhong Shi

DOI: https://doi.org/10.1186/s12890-021-01451-4

IF: 3.1

2021-03-16

BMC Pulmonary Medicine

Abstract:Abstract Background Patients with interstitial lung disease (ILD) are occasionally positive for anti-neutrophil cytoplasmic antibodies (ANCAs). Differences between ILDs secondary to microscopic polyangiitis (MPA) and isolated ANCA-positive idiopathic interstitial pneumonia (IIP) remain unclear. The aim of this study was to explore the differences in clinical features and outcomes between MPA-associated ILDs and isolated ANCA-positive IIPs. Methods We reviewed 1338 ILDs patients with available ANCA results and retrospectively analysed 80 patients who were ANCA-positive. MPA-associated ILDs (MPA-ILDs group) and isolated ANCA-positive IIPs (ANCA-IIPs group) were compared. Results Among 80 patients with ANCA-positive ILDs, 31 (38.75%) had MPA-ILDs, and 49 (61.25%) had isolated ANCA-positive IIPs. Compared with ANCA-IIPs group, patients in MPA-ILDs group had a higher proportion of fever ( p = 0.006) and higher neutrophil count ( p = 0.011), erythrocyte sedimentation rate (ESR) ( p < 0.001) and C-reactive protein (CRP) ( p = 0.005). Multivariable analysis showed that ESR level was an independent risk factor for mortality in all 80 ANCA-positive ILDs patients (HR 1.028, p = 0.001). Survival in MPA-ILDs group was lower than that in ANCA-IIPs group, and further stratified analysis revealed that ANCA-IIPs patients with elevated ESR or CRP had a worse prognosis than those with normal inflammation markers, with 5-year cumulative survival rates of 60.00%, 86.90% and 100.00% in MPA-ILDs and ANCA-IIPs with and without elevated inflammation markers, respectively. Conclusions Among patients with ANCA-positive ILDs, the prognoses of ANCA-IIPs with normal inflammation markers, ANCA-IIPs with elevated inflammation markers and MPA-ILDs were sequentially poorer. Therefore, stratified treatment should be considered in the management of ILDs patients positive for ANCAs.

respiratory system
[Clinical Characteristics and Treatment Outcomes of Microscopic Polyangiitis Combined with Autoimmune Hemolytic Anemia].

Dan Liu,Ru Li,Jia-yu Liu,Hai-hong Yao,Qin-ping Chen,Yuan Jia,Yin Su

2015-01-01

Abstract:OBJECTIVE:To investigate the clinical characteristics, laboratory features, outcome and prognosis of microscopic polyangiitis (MPA) patients with autoimmune hemolytic anemia (AIHA).METHODS:In this study, 63 cases diagnosed as MPA from October 2006 to November 2013 in Peking University People's Hospital were reviewed. The clinical characteristics, outcome and prognosis of MPA patients with AIHA were retrospectively analyzed.RESULTS:There were 12.7% (8/63) MPA patients with AIHA. The patients with AIHA had higher prevalence of fever, fatigue, hematuresis, albuminuria and new-onset hypertension, compared with non-AIHA group(87.5% vs.29.1%;100% vs. 49.1%; 100% vs. 60%; 75% vs. 20%, all P<0.05). In patients with AIHA, there were significantly lower levels of red blood cell(RBC), hemoglobin(Hb), alanine albumin(Alb) and complement C3[(2.3±0.5)×10(12)/L vs.(3.0±0.7)×10(12)/L;(66.2±13.1) g/L vs.(90.0±20.3) g/L; (26.1±4.4) g/L vs. (33.5±6.4) g/L; (0.7±0.2) g/L vs.(0.9±0.3) g/L,all P<0.05]. However, the levels of erythrocyte sedimentation rate (ESR), IgG and Birmingham Vasculitis Activity Score (BVAS) were higher, compared with those in the patients without AIHA [(102.1±25.7) mm/1 h vs.(76.5±31.1) mm/1 h; (20.9±6.1) g/L vs. (14.5±6.0) g/L; ( 23.7±5.7) vs.(17.3±4.1), all P<0.05]. The study suggested that there were more severe multi-system damage in the patients with AIHA than in those without AIHA. In the MPA patients with AIHA, six cases received treatment of methylprednisolone combined with immunosuppressant, and two received treatment of methylprednisolone only. Among the eight cases, three were recovered from anemia and four improved. One died of severe lung infection. After 4 years follow-up,in the seven MPA patients with AIHA, three received remission, two died,and two suffered from anemia and abnormal renal function.CONCLUSION:MPA with AIHA is more complicated by multi-system damage and not rare in clinical settings. Glucocorticoid combined with immunosuppressant is beneficial to induce remission for MPA patients with AIHA.
Elevated Serum Levels of Immunoglobulin A Correlate with the Possibility of Readmission in Patients with Microscopic Polyangiitis

Huijuan Wang,Chao Zhang,Zhaohui Tong,Xiaoning Bu

DOI: https://doi.org/10.21037/jtd.2017.03.166

2017-01-01

Journal of Thoracic Disease

Abstract:BACKGROUND:The evidence for the short-term prognosis of patients with microscopic polyangiitis (MPA) is weak, and the objective of this study was to analyze the clinical features of the disease and evaluate the risk factors for readmission in patients with MPA.METHODS:Fifty-seven patients with MPA were recruited into this study. The clinical data of these MPA patients were collected. Clinical manifestations, laboratory results, and imaging results were analyzed. Patients who were readmitted to our hospital within 6 months after their first diagnosis and treatment of MPA were defined as the readmission group; the remaining patients were defined as the control group.RESULTS:Respiratory symptoms, including cough, dyspnea (87.72%), and hemoptysis (3.51%), seemed to be the initial symptoms in many patients with MPA. Systemic symptoms included fever (71.93%), hearing loss (12.28%), vision loss (3.51%), and joint involvement (5.27%). The D-dimer levels of 43 patients (75.44%) were >500 ng/dL, and only three of these patients had venous thrombosis. Age and immunoglobulin A (IgA) were the risk factors for readmission in patients with MPA, with odds ratios (ORs) of 1.162 [95% confidence interval (CI): 1.025-1.317, P=0.019] and 1.010 (95% CI: 1.001-1.018, P=0.028). The days of hospitalization and the a2-globulin level were protective factors with ORs of 0.849 (95% CI: 0.725-0.993 P=0.041) and 0.789 (95% CI: 0.64-0.971, P=0.025), respectively. IgA levels were positively correlated with the number of hospitalizations, with a correlation coefficient of 0.428 (P=0.002). Receiver operating characteristic curve analysis showed that the possibility of readmission increases when the serum levels of IgA were >217.5 mg/dL.CONCLUSION:The level of serum IgA is a risk factor for the readmission of patients with MPA, and correlated with the number of hospitalizations in these patients.
Clinical and pathological characterization of patients with microscopic polyangiitis with medium artery involvement.

Ming-hui Zhao,Qi-zhi Sun,Hai-yan Wang

DOI: https://doi.org/10.1081/JDI-120026034

IF: 3.222

2015-01-01

Renal Failure

Abstract:Objective. To study the clinical and pathological characteristics of patients with microscopic polyangiitis (MPA) with medium artery involvement. Methods. Hospitalized patients with MPA in recent two years were retrospectively studied. Their clinical and pathological features were compared between patients with and without renal medium artery involvement. Results. Thirty-nine patients had renal pathology confirmed MPA. Nine cases were with medium artery involvement. For the 30 patients without medium artery involvement, 24/30 had crescentic glomerulonephritis and 11/30 also had focal segmental glomerular fibrinoid necrosis; clinically, 21/30 patients were pANCA/MPO-ANCA positive, 26/30 had acute renal failure with an average duration of 14 weeks before MPA was diagnosed, eight cases achieved complete remission after intensive immunosuppressive therapy. Nine MPA patients had medium artery involvement, manifested as segmental fibrinoid necrosis of major branch of arcuate artery, glomerulus ischemia was predominant, but crescentic lesions were mild, none of them reached crescentic glomerulonephritis. Five of the nine were pANCA/MPO-ANCA positive, eight out of the nine patients had acute renal failure with an average duration of eight weeks before diagnosed, seven of the nine achieved complete remission after intensive immunosuppressive therapy. In comparison, MPA with medium artery involvement had a shorter duration ( p < 0.05), less crescentic glomerulonephritis in patients with acute renal failure (p < 0,01) and more patients achieved complete remission after treatment (p < 0.05). Conclusion. In present study, about 23% MPA patients had medium artery involvement and their impaired renal function is mainly due to extensive glomerular ischemia. These patients progressed to acute renal failure quicker and responded to therapy better.
The Coexistence of Microscopic Polyangiitis and Rheumatoid Arthritis: A Case Report

Claudia S Villa Celi,Valeria Turcan,Juan Sosa,Natalia Plotskaya,Manish Gugnani

DOI: https://doi.org/10.7759/cureus.63885

2024-07-05

Cureus

Abstract:Microscopic polyangiitis (MPA) is a rare autoimmune disease characterized by the inflammation and necrosis of small vessels, primarily affecting kidneys and lungs. It is classified as an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) due to the presence of ANCA. MPA can manifest as diffuse alveolar hemorrhage (DAH) and rapidly progressive glomerulonephritis. In contrast, rheumatoid arthritis (RA) is an inflammatory disease that mainly targets the synovial joints. The coexistence of these two conditions presents significant diagnostic challenges, highlighting the need for further research and understanding. We report a case of a 58-year-old male with a past medical history of RA, chronic bronchitis, tobacco use, and recent Legionella pneumonia who presented with acute dyspnea. The patient was intubated for acute hypoxemic respiratory failure. Laboratory workup revealed anemia, hyponatremia, and acute kidney injury. Urinalysis showed hematuria and proteinuria. A CT scan of the chest exhibited bilateral extensive patchy infiltrates. He was transfused with one packed red blood cell (PRBC) unit. Hemoglobin decreased below 6 g/dL after transfusion. A bronchoscopy revealed erythema throughout the tracheobronchial tree, and blood on bronchial alveolar lavage suggested DAH. High-dose steroids were started. Subsequent laboratory results were positive for rheumatoid factor (RF), perinuclear ANCA (p-ANCA), anti-myeloperoxidase (anti-MPO), and antinuclear antibody (ANA). The kidney biopsy demonstrated focal crescentic necrotizing glomerulonephritis pauci-immune type, confirming MPA. RA pathogenesis involves immune dysregulation and activation of various cells, leading to the release of cytokines. Antibodies such as RF and anti-cyclic citrullinated peptide (anti-CCP) can be detected up to 10 years before the clinical manifestation of RA. Recent studies have revealed a predominance of MPA in AAV while coexisting with RA. The underlying mechanism of its occurrence remains unclear. Our patient had recurrent respiratory symptoms and renal dysfunction before hospitalization. MPA-RA overlap syndrome is potentially treatable and clinicians should maintain a high index of suspicion when encountering patients with preexisting RA. Timely initiation of immunosuppressive therapy at early stages is essential to prevent renal and pulmonary complications. ANCA serology should be assessed in these cases.
Latent class analysis of chest CT abnormalities to define subphenotypes in patients with MPO-ANCA-positive microscopic polyangiitis

Yu Gu,Ting Zhang,Min Peng,Yang Han,Weihong Zhang,Juhong Shi

DOI: https://doi.org/10.1016/j.rmed.2024.107613

IF: 4.3

2024-05-01

Respiratory Medicine

Abstract:BACKGROUND: Patients with microscopic polyangiitis (MPA) and positive myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA) may present with various abnormalities in chest computed tomography (CT). This study aimed to identify subphenotypes using latent class analysis (LCA) and to explore the relationship between the subphenotypes and clinical patterns, as well as compare the clinical characteristics of these subphenotypes in patients with MPO-ANCA-positive MPA (MPO-MPA).METHODS: The study identified subphenotypes using LCA based on chest CT findings in 178 patients with MPO-MPA and pulmonary involvement from June 2014 to August 2022.RESULTS: LCA identified 27 participants (15.2%) in class 1, 43 (24.1%) in class 2, 35 (19.7%) in class 3, and 73 (41.0%) in class 4. Class 1 was characterized by prominent inflammatory exudation, class 2 by fibrosis and architectural distortion, class 3 by predominantly bronchiectasis, and class 4 by lesions mixed with inflammation and fibrosis. Class 1 had the highest level of extrapulmonary disease activity, with 77.8% of patients experiencing diffuse alveolar hemorrhage. Class 2 had the lowest level of extrapulmonary disease activity, with 41.9% of patients showing usual interstitial pneumonia. Class 3 patients were more likely to have complications involving the ear, nose, and throat, as well as pulmonary infections before treatment, and they exhibited the best outcomes. The characteristics and outcomes of class 4 were intermediate among the four classes.CONCLUSIONS: These findings suggest that bronchiectasis may represent a unique pattern of pulmonary involvement in MPO-MPA, highlighting the importance of screening for bronchiectasis in MPO-MPA and identifying optimal management strategies.

cardiac & cardiovascular systems,respiratory system
Effects Of Mycophenolate Mofetil Combined With Corticosteroids For Induction Therapy Of Microscopic Polyangiitis

Fei Han,Guangyi Liu,Xiaohui Zhang,Xiayu Li,Qiang He,Xuelin He,Qun Li,Suya Wang,Huiping Wang,Jianghua Chen

DOI: https://doi.org/10.1159/000324364

2011-01-01

American Journal of Nephrology

Abstract:Aims: We prospectively compared the effects of oral mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVC) combined with corticosteroids for induction therapy of microscopic polyangiitis (MPA) with renal involvement over a follow-up period of 6 months. Methods: 41 MPA patients were randomly assigned to either the open-label MMF group or the IVC group. Patients in the MMF group (n = 19) received oral MMF 1.0 g/day (1.5 g/day for patients with a body weight > 70 kg) and patients in the IVC group (n = 22) received IVC in monthly pulses of 1.0 g per pulse (0.8 g per pulse for patients with a body weight < 50 kg). Both groups received intravenous methylprednisolone 360-500 mg/day for 3 days, followed by oral prednisone 0.6-0.8 mg/kg/day and gradual tapering. Results: There was no significant difference of estimated glomerular filtration rate (eGFR) level between the IVC and MMF groups at baseline. At 6 months, the eGFR level increased significantly in both groups, but there was no significant difference between the two. Three patients in the IVC group and 1 in the MMF group received maintenance dialysis within 6 months (p = 0.36). The remission rate was 63.6% in the IVC group and 78.9% in the MMF group (p = 0.23). Conclusion: MMF is effective for inducing remission in Chinese MPA patients and may represent an alternative therapy to monthly impulses of IVC. Copyright (C) 2011 S. Karger AG, Basel
The gut microbiome in microscopic polyangiitis with kidney involvement: common and unique alterations, clinical association and values for disease diagnosis and outcome prediction

Binfeng Yu,Lini Jin,Zhouwei Chen,Wanyun Nie,Liangliang Chen,Yanhong Ma,Huan Chen,Yawen Wu,Yunting Ma,Jianghua Chen,Fei Han

DOI: https://doi.org/10.21037/atm-21-1315

IF: 3.616

2021-08-01

Annals of Translational Medicine

Abstract:BACKGROUND: Microscopic polyangiitis (MPA) is an autoimmune disease characterized by frequent kidney involvement. Imbalance of intestinal flora has been found implicated in multiple immune-mediated disorders. However, the profiling and the role of the gut microbiome in MPA remains unclear.METHODS: We performed 16S rRNA amplicon sequencing on fecal samples from 71 MPA patients with kidney involvement (35 at incipient active stage, 36 at remissive stage) and 34 healthy controls (HCs). Microbial diversity and abundance were compared among the three cohorts. The correlation between altered microbes and clinical indices were investigated. Two random forest models based on the profiling of the gut microbiome were constructed for the diagnosis of MPA.RESULTS: Two α-diversity indices, including Simpson and Shannon index, were decreased in MPA patients (P<0.001), especially in those with active disease (P=0.001). β-diversity analysis showed biased microbial composition among the three groups. Genus Actinomyces and Streptococcus were more abundant in both MPA cohorts than those in HCs, while genus Subdoligranulum, Eubacterium hallii, Ruminococcaceae UCG013, Eubacterium ventriosum, Dorea and Butyricicoccus were more abundant in HCs than those in both MPA cohorts. All the 6 genera with decreased abundance belong to short-chain fatty acids (SCFA)-producing taxons. Besides, 1 and 2 operational taxonomic units (OTUs) were enriched in patients with active MPA who needed dialysis at sampling and in patients who progressed to end-stage renal disease during follow up, respectively. Furthermore, the model for diagnosis of MPA incorporated 6 OTU markers and achieved an AUC of 93.45% (95% CI, 88.15-98.74%). Similarly, the model for predicting disease activity incorporated 11 OTU markers and achieved an AUC of 90.71% (95% CI, 82.49-98.94%).CONCLUSIONS: Alteration of intestinal flora existed in MPA patients with kidney involvement and was characterized by increased abundance of genus Actinomyces and Streptococcus and decreased abundance of 6 SCFA-producing genera. Gut microbial profiling combined with machining-learning methods showed potentials for diagnosing MPA and predicting disease activity.

oncology,medicine, research & experimental
Lung Involvement of Microscopic Polyangiitis

伦立德,张波,李东明,黄志芳,刘东,高卓

DOI: https://doi.org/10.3969/j.issn.1674-3474.2006.03.004

2006-01-01

Abstract:Objective To analyze the clinical characters of lung involvement and prognosis in the patients with microscopic polyangiitis.Methods The chest radiography,CT scan and high-resolution CT were studied and analyzed in 11 patients.The effect of treatment and prognosis were obtained.Results Of these 12 patients,11 patients had pulmonary involvement,in which 9 patients were pulmonary interstitial fibrosis.All pulmonary interstitial fibrosis patients had pulmonary disfunction and high-resolution CT was needed in diagnosis.All patients showed positive P-ANCA.Conclusion Pulmonary interstitial fibrosis may occur in the early stage of microscopic polyangiitis.Renal function and HRCT should be done in the early stage of microscopic polyangiitis.
Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort

Suying Liu,Linna Han,Yanhui Liu,Jun Yang,Yu Zhang,Mengtao Li,Xinping Tian,Xiaofeng Zeng,Li Wang,Fengchun Zhang

DOI: https://doi.org/10.3389/fimmu.2022.885198

IF: 7.3

2022-06-28

Frontiers in Immunology

Abstract:Objectives: The aim of this study is to investigate the clinical significance of myeloperoxidase (MPO)–antineutrophil cytoplasmic antibody (ANCA) on eosinophilic granulomatosis with polyangiitis (EGPA) from a longitudinal Chinese cohort. Methods: A total of 120 patients with EGPA were consecutively enrolled and followed up. Two patients with PR3 ANCA was excluded and our analysis focused on the 118 patients with EGPA. On the basis of MPO-ANCA status, baseline clinical manifestations, treatment, and outcomes were analyzed. Logistic regression analysis was performed to analyze the independently associated factors for renal involvement. Results: ANCA positivity was observed in 24.2% of patients with EGPA. Patients with MPO-ANCA accounted for 20.8%. Patients with positive MPO-ANCA had higher levels of erythrocyte sedimentation rate (ESR), C-reactive protein, Birmingham Vasculitis Activity Score (BVAS), higher ratios of fever, myalgia, renal involvement, and biopsy-proven vasculitis. Heart manifestations and asthma were more common in patients with negative ANCA. Baseline MPO-ANCA titers positively correlated with ESR, eosinophil count, and BVAS and were higher in patients with methylprednisolone pulse. Among patients with renal involvement, patients with positive MPO-ANCA had higher proportions of female, fever, biopsy-proven vasculitis, and faster ESR; patients with negative ANCA developed more skin and cardiac involvement. MPO-ANCA positivity, male, and ear involvement were the independent factors associated with renal involvement. Intravenous cyclophosphamide and immunoglobulins were prescribed more frequently in patients with positive MPO-ANCA. Conclusion: In this cohort, patients with positive MPO-ANCA and negative ANCA displayed distinct clinical features, suggesting that MPO-ANCA might be a valuable biomarker for EGPA stratification. Baseline MPO-ANCA level correlated positively with disease activity of EGPA. MPO-ANCA was a significant independent factor associated with renal involvement.

immunology
Long-term Outcome of Mycophenolate Mofetil Treatment for Patients with Microscopic Polyangiitis: an Observational Study in Chinese Patients

Yinghua Chen,Erzhi Gao,Liu Yang,Xia Liu,Kang Li,Zhengzhao Liu,Caihong Zeng,Haitao Zhang,Zhihong Liu,Weixin Hu

DOI: https://doi.org/10.1007/s00296-016-3492-5

2016-01-01

Rheumatology International

Abstract:This study aimed to retrospectively analyze the long-term outcome of mycophenolate mofetil (MMF) therapy for microscopic polyangiitis (MPA) with mild to moderate renal involvement in Chinese patients. Thirty-four MPA patients (24 females, 10 males, aged 44.7 ± 17 years, BVAS score 13.8 ± 3.2, SCr 2.2 ± 1.1 mg/dl) with SCr < 5 mg/dl and who received glucocorticoids plus MMF therapy for inducing and maintaining remission were included in this study. The remission and relapse rates, patient and renal survival rates and adverse events were retrospectively analyzed. We found that 31 (91.2 %) of 34 patients achieved remission and were continuously treated with glucocorticoids plus MMF for maintaining remission. The median duration of MMF treatment was 24 months (IQR 15–53 months) and follow-up time was 86 months (IQR 29–124 months). During the follow-up, 7 (22.6 %) patients relapsed, one patient died, and one patient progressed into end-stage renal disease. The 5-year patient and renal survival rates were 92.8 and 95.2 %, respectively. 11 (32.4 %) patients suffered 16 adverse events, 13 of which were pulmonary infection. In conclusion, glucocorticoids plus MMF regimen as induction and maintenance therapy could achieve high remission rate and good long-term renal survival in MPA patients with mild to moderate renal involvement. Prospective controlled trials with a large sample size are needed to confirm the efficacy of MMF in this population.
Prognostic Value of Concomitant Bronchiectasis in Newly Diagnosed Diffuse Panbronchiolitis Patients on a Maintenance Therapy with Macrolides

Benyong Xu,Yanhua Mao,Xiaoyu Wan,Jianhui Chen,Meiping Ye,Mengling Zhan,Liyun Xu,Lan Zhao,Bing Li,Zhemin Zhang,Yang Liu,Haiqing Chu

DOI: https://doi.org/10.1155/2019/4913814

2019-01-01

Canadian Respiratory Journal

Abstract:Background. Factors determining the prognosis of diffuse panbronchiolitis (DPB) remain unclear at present. The objective of this study was to identify the prognostic value of concomitant bronchiectasis in the macrolide treatment efficacy and exacerbation risk in DPB patients. Methods. Data of patients initially diagnosed with DPB at the Shanghai Pulmonary Hospital between January 2007 and December 2017 were retrospectively collected and analyzed. The patients were divided into two groups according to the existence of bronchiectasis. Clinical manifestations, laboratory findings, microbiological culture results, as well as exacerbation risks and treatment outcomes, were compared between these two groups. The survival curve and Cox regression analysis models were additionally constructed to further demonstrate the predicting role of bronchiectasis in DPB exacerbation. Results. Baseline data revealed more respiratory symptoms, lower body mass index (BMI), and forced expiratory volume in one second (FEV1) as well as increased isolates of Pseudomonas aeruginosa (P. aeruginosa) in DPB subjects with bronchiectasis than those without. Furthermore, bronchiectasis was associated with a lower rate of responsiveness to macrolides and increased exacerbation frequency during follow-up. The survival curve and Cox regression analysis showed that comorbid bronchiectasis was linked to increased time to episode relapse, which remained significant even after controlling for BMI, FEV1, and P. aeruginosa culture results. Conclusion. The coexistence of bronchiectasis predicted a poor outcome of maintenance macrolide therapy and an increased exacerbation risk in DPB subjects, possibly through its impacts on nutritional status, pulmonary function, and P. aeruginosa infections.
Photometric reconstruction from images: new scenarios and approaches for uncontrolled input data

J. Ackermann

2014-04-23

Abstract:The changes in surface shading caused by varying illumination constitute an important cue to discern fine details and recognize the shape of textureless objects. Humans perform this task subconsciously, but it is challenging for a computer because several variables are unknown and intermix in the light distribution that actually reaches the eye or camera. In this work, we study algorithms and techniques to automatically recover the surface orientation and reflectance properties from multiple images of a scene. Photometric reconstruction techniques have been investigated for decades but are still restricted to industrial applications and research laboratories. Making these techniques work on more general, uncontrolled input without specialized capture setups has to be the next step but is not yet solved. We explore the current limits of photometric shape recovery in terms of input data and propose ways to overcome some of its restrictions. Many approaches, especially for non-Lambertian surfaces, rely on the illumination and the radiometric response function of the camera to be known. The accuracy such algorithms are able to achieve depends a lot on the quality of an a priori calibration of these parameters. We propose two techniques to estimate the position of a point light source, experimentally compare their performance with the commonly employed method, and draw conclusions which one to use in practice. We also discuss how well an absolute radiometric calibration can be performed on uncontrolled consumer images and show the application of a simple radiometric model to re-create night-time impressions from color images. A focus of this thesis is on Internet images which are an increasingly important source of data for computer vision and graphics applications. Concerning reconstructions in this setting we present novel approaches that are able to recover surface orientation from Internet webcam images. We explore two different strategies to overcome the challenges posed by this kind of input data. One technique exploits orientation consistency and matches appearance profiles on the target with a partial reconstruction of the scene. This avoids an explicit light calibration and works for any reflectance that is observed on the partial reference geometry. The other technique employs an outdoor lighting model and reflectance properties represented as parametric basis materials. It yields a richer scene representation consisting of shape and reflectance. This is very useful for the simulation of new impressions or editing operations, e.g. relighting. The proposed approach is the first that achieves such a reconstruction on webcam data. Both presentations are accompanied by evaluations on synthetic and real-world data showing qualitative and quantitative results. We also present a reconstruction approach for more controlled data in terms of the target scene. It relies on a reference object to relax a constraint common to many photometric stereo approaches: the fixed camera assumption. The proposed technique allows the camera and light source to vary freely in each image. It again avoids a light calibration step and can be applied to non-Lambertian surfaces. In summary, this thesis contributes to the calibration and to the reconstruction aspects of photometric techniques. We overcome challenges in both controlled and uncontrolled settings, with a focus on the latter. All proposed approaches are shown to operate also on non-Lambertian objects.

[Neurologic disorders and cervical spina bifida occulta].

Chest CT features of microscopic polyangiitis

The Lung Involvement of Microscopic Polyangiitis

Manifestation and long-term prognosis in microscopic polyangiitis patients with pulmonary involvement

Long-term clinical course and outcomes of patients with microscopic polyangiitis-associated interstitial lung disease

Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: A single-center retrospective study

[Clinical characteristics of 15 cases of microscopic polyangiitis associated with alveolar hemorrhage].

The Clinical and Pathological Features of Children With Microscopic Polyangiitis

Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody

[Clinical Characteristics and Treatment Outcomes of Microscopic Polyangiitis Combined with Autoimmune Hemolytic Anemia].

Elevated Serum Levels of Immunoglobulin A Correlate with the Possibility of Readmission in Patients with Microscopic Polyangiitis

Clinical and pathological characterization of patients with microscopic polyangiitis with medium artery involvement.

The Coexistence of Microscopic Polyangiitis and Rheumatoid Arthritis: A Case Report

Latent class analysis of chest CT abnormalities to define subphenotypes in patients with MPO-ANCA-positive microscopic polyangiitis

Effects Of Mycophenolate Mofetil Combined With Corticosteroids For Induction Therapy Of Microscopic Polyangiitis

The gut microbiome in microscopic polyangiitis with kidney involvement: common and unique alterations, clinical association and values for disease diagnosis and outcome prediction

Lung Involvement of Microscopic Polyangiitis

Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort

Long-term Outcome of Mycophenolate Mofetil Treatment for Patients with Microscopic Polyangiitis: an Observational Study in Chinese Patients

Prognostic Value of Concomitant Bronchiectasis in Newly Diagnosed Diffuse Panbronchiolitis Patients on a Maintenance Therapy with Macrolides

Photometric reconstruction from images: new scenarios and approaches for uncontrolled input data